LC
LMAT icon

Lindbrook Capital’s LeMaitre Vascular LMAT Stock Holding History

Lindbrook Capital’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$3.78K Buy
45
+19
+73% +$1.77K ﹤0.01% 2069
2024
Q4 		$2.4K Sell
26
-3
-10% -$289 ﹤0.01% 2259
2024
Q3 		$2.69K Hold
29
– – ﹤0.01% 2255
2024
Q2 		$2.39K Buy
29
+10
+53% +$735 ﹤0.01% 2290
2024
Q1 		$1.26K Hold
19
– – ﹤0.01% 2373
2023
Q4 		$1.08K Buy
+19
New +$995 ﹤0.01% 2450
2022
Q4 		– Sell
-6
Closed – – 2927
2022
Q3 		$0 Buy
+6
New +$300 ﹤0.01% 2782

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lindbrook Capital's LMAT Position: Q1 2025 in Review

Lindbrook Capital increased its LeMaitre Vascular (LMAT) stake by 73% in Q1 2025, buying an estimated $1.77K and bringing the position to 45 shares worth $3.78K. The position accounts for ﹤0.01% of the portfolio, ranked #2069.

Lindbrook Capital first reported a position in LMAT in Q3 2022 and has held it in 7 quarters since. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

  • Lindbrook Capital held 45 shares of LeMaitre Vascular worth $3.78K as of Q1 2025.
  • Lindbrook Capital bought 19 LeMaitre Vascular shares in Q1 2025, an estimated $1.77K.
  • LeMaitre Vascular made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2069 holding.
  • Lindbrook Capital first reported a position in LeMaitre Vascular in Q3 2022 and has held it in 7 quarters since.
  • 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.